Parkinson's Disease Study from The Michael J. Fox Foundation

MIAMI - Nov. 6, 2018 - EntSun -- A new online Parkinson's disease study is available from The Michael J. Fox Foundation by Fox Insight. Fox Insight is an online clinical study where people with Parkinson's disease and their loved ones share information that could transform the search for better treatments. By joining Fox Insight you can help shape the future of Parkinson's research — but it's going to take all of us, working together.

No one understands Parkinson's better than those living with it every day. By working together, we can help shape the future of research. Fox Insight easily collects self-reported data about health experiences from those with and without Parkinson's in a number of ways. Eligible individuals can help researchers gain a holistic picture of the disease by participating in a genetic sub-study.

More on EntSun News

• Collision Course Concert Series Returns to Atlanta
• $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
• West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
• BayView Entertainment, Inc. Releases Multi Award-Winning Horror Film 'The Forest Through the Trees'
• Germantown Fashion & Arts Festival 2025 Draws Thousands, Celebrates Creativity in Historic Philly

Fox Insight Parkinson's Disease Study

Fox Insight is an online clinical study that empowers patients, control volunteers and researchers to work together toward Parkinson's disease breakthroughs.

The flexible study design allows participants to contribute data in a variety of ways:

• Routine health-related surveys
• Optional, add-on surveys and sub-studies including genetic testing
• Future remote data collection (e.g. wearables, keyboard tapping, biologic samples)

Fox Insight Parkinson's Disease Participants

Fox Insight participants complete virtual study visits every 3 months, and data they contribute enables high-impact scientific collaboration toward patient-relevant outcomes.

Through online study visits (45 to 60 minutes), participants fill out a series of questionnaires to provide critical insights on:

• Symptoms
• Physical function
• Medications
• Quality of life
• Unmet Needs
• Healthcare preferences

Additional research opportunities such as add-on questionnaires and sub-studies will be integrated into the Fox Insight platform.

More on EntSun News

• The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
• Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
• New Media Film Festival Announces Winners
• New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
• The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side

Fox Insight is currently enrolling anyone who:

• Is 18 years old or older
• Has a Parkinson's diagnosis
• Is able to complete health questionnaires in English
• Has access to the internet

Over 22,000 participants are already contributing information about their experience with Parkinson's disease (PD).

By participating in genetics research, Parkinson's disease patients can help speed the development process toward personalized therapies that may slow or stop the disease. For more information about the study, visit First Choice Neurology blog at https://www.fcneurology.net/parkinsons-disease-study-from-the-michael-j-fox-foundation/